相关实验视频

Updated: Jan 11, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

在视觉周鼻炎中对髓寡基细胞糖蛋白的抗体

Shanshan Cao^1,2, Yuan Zhang³, Xintong Xu¹

¹Senior Department of Ophthalmology, Chinese People's Liberation Army General Hospital & Chinese PLA Medical School, Beijing, China.

Frontiers in immunology

|November 14, 2025

概括

在24.2%的视膜尿道炎 (OPN) 病例中,存在髓类寡基细胞糖蛋白抗体 (MOG-IgG). 具有MOG-IgG阳性的OPN患者出现更年轻的发病率,更高的复发率和更好的视力恢复.

科学领域:

神经科学是一个神经科学.
眼科医生眼科眼科
免疫学免疫学免疫学

背景情况:

视神经周脉炎 (OPN) 是一种炎症状况,影响视神经外.
髓寡细胞糖蛋白抗体 (MOG-IgG) 与各种神经炎症疾病有关.
在OPN中MOG-IgG的作用需要进一步阐明.

研究的目的:

为了确定OPN患者中MOG-IgG的患病率.
描述MOG-IgG血清阳性的OPN的临床特征.
分析MOG-IgG阳性OPN患者的视觉预后.

主要方法:

从2020年1月到2023年2月对OPN患者的回顾性评估.
使用基于细胞的测定 (CBA) 将MOG-IgG阳性和血清阴性分类.
群体之间的人口,临床和视觉结果数据的比较.

主要成果:

在33名OPN患者中,MOG-IgG在24.2%的患者中被检测到.
阳性MOG-IgG患者的年龄明显较小 (20.8岁对36.6岁),复发率较高 (1.19岁对0.31岁).
在MOG-IgG-阳性患者中观察到优异的视力敏度恢复 (100% ≥20/40事件后与45.5%相比).

结论:

具有MOG-IgG阳性的OPN具有明显的特征:年龄较小,复发率增加,视觉结果更好.
MOG-IgG检测有助于早期诊断和预测OPN的预后.
识别MOG-IgG状态可以指导OPN个性化治疗策略.

关键词:

骨髓分子基蛋白抗体 - - 骨髓分子基蛋白抗体神经眼科神经眼科视觉周神经管炎 (optic perineuritis) 是一种视觉周神经管炎.复发率是什么意思?复发率是什么意思?视觉预后视觉预后

更多相关视频

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...